82 related articles for article (PubMed ID: 2475558)
1. [Prevention of cisplatin induced nephrotoxicity by administering urinastatin to rabbits--comparison with other protease inhibitors].
Kobayashi H; Ohi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):683-7. PubMed ID: 2475558
[TBL] [Abstract][Full Text] [Related]
2. [Preventive effect of urinastatin on cisplatin induced nephrotoxicity in rabbits].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):328-32. PubMed ID: 2567322
[TBL] [Abstract][Full Text] [Related]
3. [Preventive effect of urinastatin on cisplatin-induced nephrotoxicity].
Kobayashi H; Ishizuka H; Hirashima Y; Ohi H; Demukai H; Moniwa M; Maeda M; Kobayashi T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1959-64. PubMed ID: 2592819
[TBL] [Abstract][Full Text] [Related]
4. [Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):888-96. PubMed ID: 4040542
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of urinastatin on ischemic renal injury in rabbits].
Kihara K; Nagata N; Takasaki M
Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):673-7. PubMed ID: 1684217
[TBL] [Abstract][Full Text] [Related]
6. [Study on gamma-GTP activity in urine and renal tissue of drug-induced nephrotoxicity in rats].
Furuta N; Nakada J
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1197-205. PubMed ID: 8102655
[TBL] [Abstract][Full Text] [Related]
7. [Study on urinary gamma-GTP activities as an indicator of cis-diamminedichloride platinum nephrotoxicity].
Takahashi T; Yoshida K; Nakame Y; Saitoh H
Hinyokika Kiyo; 1986 Jun; 32(6):789-94. PubMed ID: 2876605
[TBL] [Abstract][Full Text] [Related]
8. Prevention by urinastatin of cis-diamminedichloroplatinum-induced nephrotoxicity in rabbits: comparison of urinary enzyme excretions and morphological alterations by electron microscopy.
Kobayashi H; Ohi H; Terao T
Asia Oceania J Obstet Gynaecol; 1991 Sep; 17(3):277-88. PubMed ID: 1953441
[TBL] [Abstract][Full Text] [Related]
9. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
Takahashi T; Yoshida K; Nakame Y; Saitoh H
Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
[TBL] [Abstract][Full Text] [Related]
10. [Effects of urinastatin against nephrotoxicity of cisplatinum].
Arakawa A; Kato N; Asai H; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2229-34. PubMed ID: 2241187
[TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney.
Paolicchi A; Sotiropuolou M; Perego P; Daubeuf S; Visvikis A; Lorenzini E; Franzini M; Romiti N; Chieli E; Leone R; Apostoli P; Colangelo D; Zunino F; Pompella A
Eur J Cancer; 2003 May; 39(7):996-1003. PubMed ID: 12706370
[TBL] [Abstract][Full Text] [Related]
12. [Prophylactic effect of ulinastatin on cisplatin-induced renal disorders in lung cancer patients].
Horiguchi T; Kasahara J; Ogura K; Handa M; Hosoda H; Shakato A; Tachikawa S; Sato M; Suetsugu S; Umeda H
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):12-9. PubMed ID: 1625386
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
Najjar TA; Saad SY
Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Hanigan MH; Gallagher BC; Taylor PT; Large MK
Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
Yogi S; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
[TBL] [Abstract][Full Text] [Related]
16. Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells.
Zhang JS; Kadowaki D; Nonoguchi H; Hirata S; Seo H; Imai T; Suenaga A; Giam Chuang VT; Otagiri M
Ren Fail; 2011; 33(6):609-14. PubMed ID: 21631182
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
18. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
Ino Y; Suzuki K; Sato T; Iwaki M
Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
[TBL] [Abstract][Full Text] [Related]
20. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
Tay LK; Bregman CL; Masters BA; Williams PD
Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
